UK markets closed

Inari Medical, Inc. (NARI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
68.66+0.67 (+0.99%)
At close: 04:00PM EDT
69.49 +0.83 (+1.21%)
After hours: 07:39PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
306,339
276,984
139,670
51,129
6,829
Cost of revenue
30,101
24,757
13,106
5,910
1,281
Gross profit
276,238
252,227
126,564
45,218
5,548
Operating expenses
Research development
58,990
51,018
18,399
7,220
3,990
Selling general and administrative
217,199
190,365
89,746
37,197
10,698
Total operating expenses
276,189
241,383
108,145
44,417
14,688
Operating income or loss
49
10,844
18,419
801.494
-9,140
Interest expense
295
295
1,135
920.459
887
Total other income/expenses net
-1
-18
-3,979
-1,162
-218
Income before tax
-111
10,685
13,789
-1,192
-10,153
Income tax expense
647
845
-
-
-
Income from continuing operations
-758
9,840
13,789
-1,192
-10,153
Net income
-758
9,840
13,789
-1,192
-10,153
Net income available to common shareholders
-758
9,840
13,789
-1,192
-10,153
Basic EPS
-
0.20
0.43
-0.03
-0.26
Diluted EPS
-
0.18
0.27
-0.03
-0.26
Basic average shares
-
49,816
32,034
37,856
38,367
Diluted average shares
-
55,594
51,555
37,856
44,953
EBITDA
-
15,288
16,309
342.154
-8,983